한국형 양극성 장애 약물치료 알고리듬 2022: 동반 신체질환Korean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical IllnessesKorean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical Illnesses
- Other Titles
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical IllnessesKorean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical Illnesses
- Authors
- 정명훈; 박원명; 우영섭; 정종현; 윤보현; 서정석; 양찬모; 김원; 이정구; 심세훈; 추일한; 박성용; 손인기; 전덕인; 김문두
- Issue Date
- Nov-2022
- Publisher
- 대한신경정신의학회
- Keywords
- Bipolar disorder; Comorbid physical illnesses; Pharmacotherapy; KMAP-BP 2022.
- Citation
- JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, v.61, no.4, pp 267 - 273
- Pages
- 7
- Journal Title
- JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION
- Volume
- 61
- Number
- 4
- Start Page
- 267
- End Page
- 273
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21991
- ISSN
- 1015-4817
2289-0963
- Abstract
- Objectives The present study was carried out to revise the guidelines for the Korean Medica tion Algorithm Project for Bipolar Disorder (KMAP-BP) 2018. The revision was carried out based on expert opinions to facilitate clinical decisions related to the treatment of bipolar disorders in patients with comorbid physical illnesses.
Methods A 56-item questionnaire was developed; a consensus was arrived at by 87 out of 93 experts (93.5%), on the pharmacological treatment strategies to be used in cases of comorbid physical illnesses accompanying bipolar disorders.
Results For patients with bipolar disorder exhibiting comorbid conditions, by consensus, la motrigine, aripiprazole, and ziprasidone were recommended as the first-line strategies for metabolic syndrome; lamotrigine and aripiprazole were the recommended first-line strategies for cardiovas cular problems; lithium and aripiprazole were the recommended first-line strategies for haptic problems; valproate, lamotrigine, aripiprazole, and quetiapine were the recommended first-line strategies for renal problems; and valproate and aripiprazole were the recommended first-line strategies for cerebrovascular problems or cerebral damage.
Conclusion The present study is the most recent consensus among experts on recommenda tions for the treatment of bipolar disorders in patients with comorbid physical illnesses. Aripipra zole was recommended as the first-line pharmacotherapeutic agent in five comorbid physical conditions. This recommendation is similar to KMAP-BP 2018. Additionally, lamotrigine has been added as a first -line pharmacotherapeutic agent in patients with the metabolic syndrome, car diovascular problems, and renal problems in the current algorithm.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Psychiatry > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21991)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.